Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer

RECOMMENDED

Pregnancy and Childbirth

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

Cancer.

Lambertini M, Martel S, Campbell C, Guillaume S, Hilbers FS, Schuehly U, Korde L, Azim HA, Jr, Di Cosimo S, Tenglin RC, Huober J, Baselga J, Moreno-Aspitia A, Piccart-Gebhart M, Gelber RD, de Azambuja E, Ignatiadis M

doi: 10.1002/cncr.31784.

Uro-Oncology

Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer

PLoS One.

Bausch K, Roth E, Heinz S, Horst D, Mathia S, Vlajnic T, Bubendorf L, Westhoff T, Wetterauer C, Seifert HH, Ebbing J

doi: 10.1371/journal.

Uro-Oncology

Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

Eur Urol.

Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A, Catto JWF

doi: 10.1016/j.eururo.

Uro-Oncology

Reproductive and hormonal factors and bladder cancer risk: a prospective study and meta-analysis

Aging (Albany NY).

Xu X, Mo Q, Shen H, Wang S, Liu B

doi: 10.18632/aging.103523.

Overactive BladderUro-Oncology

An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups

Urol Oncol.

Bosschieter J, Nieuwenhuijzen JA, Vis AN, van Ginkel T, Lissenberg-Witte BI, Beckers GMA, van Moorselaar RJA

doi: 10.1016/j.urolonc.2018.05.026.

Uro-Oncology

Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme

Eur Urol.

Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative

doi: 10.1016/j.eururo.2020.06.051.

Uro-Oncology

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial

World J Urol.

Sell V, Ettala O, Montoya Perez I, Järvinen R, Pekkarinen T, Vaarala M, Seppänen M, Liukkonen T, Marttila T, Aaltomaa S, Kaasinen E, Boström PJ

doi: 10.1007/s00345-

Overactive BladderUro-Oncology

Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients

Eur Urol.

Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJ

doi: 10.1016/j.eururo.2017.06.038.

Uro-Oncology

A Systematic Review on Mutation Markers for Bladder Cancer Diagnosis in Urine

BJU Int.

Hentschel AE, van EE, der Toom, Vis AN, Ket JCF, Bosschieter J, Heymans MW, van Moorselaar RJA, Steenbergen RDM, Nieuwenhuijzen JA

doi: 10.1111/bju.15137.

Related content

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer

Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

Reproductive and hormonal factors and bladder cancer risk: a prospective study and meta-analysis

An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups

Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial

Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients

A Systematic Review on Mutation Markers for Bladder Cancer Diagnosis in Urine